Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.
Negocios · 27/1/19981 min de lectura
Xytronyx, Inc.; Premarket Approval of the Periogard Periodontal Tissue Monitor
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA) is announcing its approval of the application by Xytronyx, Inc., San Diego, CA, for premarket approval, under the Federal Food, Drug, and Cosmetic Act (the act), of the Periogard Periodontal Tissue Monitor (PTM). After reviewing the recommendation of the Devices Panel, FDA's Center for Devices and Radiological Health (CDRH) notified the applicant, by letter of June 23, 1997, of the approval of the application.
Idioma original de la fuente: Federal Register — Food and Drug AdministrationAbrir el comunicado original →